Clinical Trial: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metabolic Syndrome
Study Type: INTERVENTIONAL
Official Title: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
Brief Summary:
Coronary vascular dysfunction is one of the "final common pathways" for the impact of multiple cardiovascular risk factors.The investigators will conduct a randomized, double-blind placebo-controlled study in individuals with the metabolic syndrome and baseline coronary vascular dysfunction to evaluate the impact of vericiguat, a stimulator of soluble guanylyl cyclase, on coronary vascular function using non-invasive cardiac magnetic resonance imaging.
Read more